June 15, 2018
In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- McGuireWoods
- Wexler Boley
- Smith Segura Raphael & Leger
- Durrette Arkema
- Winston & Strawn
- Girard Sharp
- Grabar Law
- Garwin Gerstein
- Kaufman & Canoles
- Ventker Henderson
- McDermott Will & Emery
- Williams & Connolly
- Berger Montague
- Heins Mills
- DurretteCrump
- Duncan & Allen
- Cohen Milstein
- Miller Shah LLP
- Wolcott Rivers
- Morgan Lewis
- Goldman Ismail
- Faruqi & Faruqi
- Motley Rice
- Hangley Aronchick
- Katten Muchin
- Kirkland & Ellis
- Radice Law Firm
- Glasser & Glasser
- Lockridge Grindal
- DLA Piper
- Willcox & Savage
- Zelle LLP
- Marcus & Shapira
- O'Hagan Meyer
- Hilliard & Shadowen
- BoiesBattin
- Boies Schiller
- The Office of Craig C. Reilly
- Nussbaum Law Group
- Gibson Dunn
- Crenshaw Ware
- Kessler Topaz
- Gustafson Gluek
- Wilson Sonsini
- Joseph Saveri Law Firm
- Hartley LLP
- Furniss Davis
- Fisher & Phillips
- Hagens Berman
- Sperling & Slater
- Crowell & Moring
- Taus Cebulash
- Woods Rogers
- Glancy Prongay
- Labaton Keller
- White & Case
Companies
- CVS Health Corp.
- J.M. Smith Corp.
- WellCare Health Plans Inc.
- Fraternal Order of Police
- The Kroger Co.
- Glenmark Pharmaceuticals Ltd.
- Health Net Inc.
- H.D. Smith LLC
- Cencora Inc.
- Rite Aid Corp.
- Albertsons Cos. Inc.
- Mutual Drug
- Humana Inc.
- Supervalu Inc.
- Par Pharmaceutical Cos. Inc.
- Rochester Drug Cooperative Inc.
- McKesson Corp.
- United Food & Commercial Workers International Union
- Wegmans Food Markets Inc.
- H‑E‑B LP
- Cardinal Health Inc.
- Merck & Co. Inc.
- Zydus Pharmaceuticals Inc.
- Centene Corp.
- Giant Eagle Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 27, 2023
Merck Says It Paid $573M To Settle Zetia Antitrust Case
Pharmaceutical giant Merck & Co. Inc. paid $573 million to settle antitrust claims this month over allegations it conspired with Glenmark Pharmaceuticals to delay the launch of generic versions of the blockbuster cholesterol drug Zetia, according to first-quarter financial results released Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login